ICBII Announces Approval of Its 7th Patent on Blood-Brain Barrier Permeable Technology, Moving Closer to Clinical Trials on its drugs for Alzheimer's, Parkinson's, and Other Neuro-Degenerative Diseases

LA JOLLA, Calif., Sept. 22, 2021 /PRNewswire/ -- Innovative California Biosciences International, Inc., ("ICBII"), has announced the approval of its 7th patent for Blood-Brain Barrier (BBB) Permeable Peptide Compositions.